Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis
Conclusions:
In terms of fecal SCFAs, there were differences between patients with IBS and HCs. In IBS-C patients, propionate and butyrate were reduced, whereas butyrate was increased in IBS-D patients in comparison to HCs. Propionate and butyrate could be used as biomarkers for IBS diagnosis.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
More News: Constipation | Databases & Libraries | Diets | Internal Medicine | Irritable Bowel Syndrome | Nutrition | Study